Pharmafile Logo

Genesis Research Group’s ISPOR Europe award-winning poster authors interviewed online

Genesis Research Group’s poster ‘Payer Perspective on the Impact of Real-world Evidence in Health Technology Assessments of Precision Oncology Treatments Across Europe: Results From an Online Survey’ was recently named as ‘Best General Poster Research Presentation’ for ISPOR Europe 2024.

Along with other Genesis Research Group presentations, the poster has recently been featured by The Evidence Base in an interview entitled ‘Payer Perspectives on Key Challenges in Healthcare Decision-Making: actionable insights for life sciences companies’.

Ispor Europe poster winning authors

Prior to being awarded ‘Best General Poster Research Presentation‘ for ISPOR Europe 2024, authors of the poster ‘Payer Perspective on the Impact of Real-world Evidence in Health Technology Assessments of Precision Oncology Treatments Across Europe: Results From an Online Survey‘ were interviewed by The Evidence Base alongside other Genesis Research Group authors.

Payer perspectives are essential in ensuring that new treatments demonstrate not only clinical efficacy but also cost-effectiveness, while aligning with the priorities and sustainability of healthcare systems. For life sciences companies, understanding payer approaches to the complex challenges of reimbursement decision-making—including budget impact assessments, cost-effectiveness analyses, and evaluations of clinical value—is critical for shaping patient access to innovative therapies and informing healthcare policy.

In this interview, The Evidence Base spoke with Tijana Ignjatovic, Darrin Benjumea, and Manica Agrawal about new research that focuses on gathering payer perspectives on these key issues in healthcare. The survey results were recently presented at ISPOR Europe 2024 (November 17–20, 2024, Barcelona, Spain).

Darren Benjumea was the co-author and presenter of the previously mentioned ISPOR Europe winning poster, the additional authors being Tijana Ignjatovic, Alice Jackson, Kristen Downs, and Lynn Okamoto.

Congratulations to the Genesis Research Group team!

You can read the article online or contact Genesis Research Group at solutions@genesisrg.com if you’d like a copy of the poster.

This content was provided by Genesis Research Group

Company Details

 Latest Content from  Genesis Research Group 

Genesis Research and Clinical Outcomes Solutions announce innovative partnership

International Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) organization Genesis Research is delighted to announce an exciting new partnership with Clinical Outcomes Assessment (COA) specialist Clinical Outcomes...

Genesis Research Acquires Market Access Transformation

Genesis Research, a leading provider of tech-enabled Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) services, has entered into a definitive agreement to acquire Market Access Transformation (“MAT”),...

GHO Capital Acquires Genesis Research

GHO Capital Partners LLP, the European specialist investor in global healthcare, announces the acquisition of Genesis Research, a leading provider of tech-enabled Real-World Evidence (RWE) and Health Economics and Outcomes...

Genesis Research: What is EVID AI?

Genesis Research Announces Significant Enhancements to EVID AI, the World's Largest AI-Enabled Healthcare Literature Database for Faster, More Efficient Searches